Trulieve CEO: Medical Cannabis Transition | Mad Money | CNBC thumbnail

Trulieve CEO: Medical Cannabis Transition | Mad Money | CNBC

It’s a medical marijuana company helping over 80,000 patients and you may have never heard of it. Jim Cramer looks into Trulieve and what it can tell us about the…

GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC thumbnail

GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC

Canada’s marijuana legalization may be all the rage, but one drug company has been working for years to create real cannabis-based medicine. Jim Cramer hears from GW Pharma’s CEO about…

Green Thumb Industries CEO: ‘Credentializing’ Cannabis | Mad Money | CNBC thumbnail

Green Thumb Industries CEO: ‘Credentializing’ Cannabis | Mad Money | CNBC

The whole cannabis cohort has been smoking hot, but not all pot stocks are created equal. Jim Cramer checks in with the CEO of growth-focused Green Thumb Industries to try…